COVID-19 is associated with severe thrombotic complications, both micro- and macrovascular lesions, mainly deep vein thrombosis, pulmonary embolism, primary pulmonary artery thrombosis, up to a syndrome similar to intravascular coagulation
Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease that has quickly be...
Background The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global (COVID-19) pandem...
COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher ris...
COVID-19 is a very complex and formidable disease that has a systemic nature involving almost all or...
The ongoing pandemic of novel coronavirus 2019 is rapidly evolving, and newer organ- and system-spec...
The novel coronavirus infection named COVID-19 was first detected in Wuhan, China, in December 2019,...
Hemostatic disorders play an important role in the pathogenesis and clinical manifestations of COVID...
Аt present, it can be noted without exaggeration that COVID-19 is the most serious challenge to the ...
The novel coronavirus disease first appeared in Wuhan (China) is an infectious disease spreading thr...
Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics...
A potential link between mortality, D-dimer values and a prothrombotic syndrome has been reported in...
Introduction: Emerging evidence points to an association between severe clinical presentation of COV...
The role of coagulopathy in severe novel coronavirus infection remains to be clarified. Coagulopathy...
Coronavirus Disease 2019 (COVID-19) has had an enormous impact on both the medical community as wel...
The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also known as COVID-19...
Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease that has quickly be...
Background The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global (COVID-19) pandem...
COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher ris...
COVID-19 is a very complex and formidable disease that has a systemic nature involving almost all or...
The ongoing pandemic of novel coronavirus 2019 is rapidly evolving, and newer organ- and system-spec...
The novel coronavirus infection named COVID-19 was first detected in Wuhan, China, in December 2019,...
Hemostatic disorders play an important role in the pathogenesis and clinical manifestations of COVID...
Аt present, it can be noted without exaggeration that COVID-19 is the most serious challenge to the ...
The novel coronavirus disease first appeared in Wuhan (China) is an infectious disease spreading thr...
Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics...
A potential link between mortality, D-dimer values and a prothrombotic syndrome has been reported in...
Introduction: Emerging evidence points to an association between severe clinical presentation of COV...
The role of coagulopathy in severe novel coronavirus infection remains to be clarified. Coagulopathy...
Coronavirus Disease 2019 (COVID-19) has had an enormous impact on both the medical community as wel...
The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also known as COVID-19...
Coronavirus disease 2019 (COVID-19) is a newly emerging human infectious disease that has quickly be...
Background The novel coronavirus SARS-CoV-2, responsible for the 2019–2020 global (COVID-19) pandem...
COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher ris...
DOI
Add to ORKG